Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia

被引:30
作者
Chan, Paul K. S. [1 ]
Cheung, Jo L. K.
Cheung, Tak-Hong
Lo, Keith W. K.
Yim, So-Fan
Siu, Shing-Shun N.
Tang, Julian W.
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1086/520884
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The clinical utility of viral-load and integration status of human papillomavirus (HPV) infection remains uncertain. We examined 75 women infected with HPV58, a worldwide rare type found to be prevalent in cervical cancers in eastern Asia. Viral load was significantly higher for cervical intraepithelial neoplasia (CIN) 1/2, but those for a normal control group and for CIN 3 or cancer overlapped substantially. A pure integrated genome was found for all lesion grades, giving a poor positive predictive value (23.1%) for cancer. The pure episomal form's negative predictive value for cancer was only 76.3%. Mixed patterns of E2 gene disruption were common and often involved the amino-terminal and hinge regions. Disruption of the whole E2 gene was rare and was restricted to high-grade lesions. The HPV58 variant E67-HK-2 was more likely to exist in the pure episomal form. Routinely collected cervical samples contain a heterogeneous population of viruses, hampering the application of viral load and integration testing in clinical settings.
引用
收藏
页码:868 / 875
页数:8
相关论文
共 41 条
[1]   Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN) [J].
Andersson, S ;
Safari, H ;
Mints, M ;
Lewensohn-Fuchs, I ;
Gyllensten, U ;
Johansson, B .
BRITISH JOURNAL OF CANCER, 2005, 92 (12) :2195-2200
[2]   Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer [J].
Arias-Pulido, Hugo ;
Peyton, Cheri L. ;
Joste, Nancy E. ;
Vargas, Hernan ;
Wheeler, Cosette M. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (05) :1755-1762
[3]   HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness [J].
Badaracco, G ;
Venuti, A ;
Sedati, A ;
Marcante, ML .
JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (04) :574-582
[4]   Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil [J].
Camara, GNL ;
Cerqueira, DM ;
Oliveira, APG ;
Silva, EO ;
Carvalho, LGS ;
Martins, CRF .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2003, 98 (07) :879-883
[5]   Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers [J].
Chan, PKS ;
Cheung, TH ;
Tam, AOY ;
Lo, KWK ;
Yim, SF ;
Yu, MMY ;
To, KF ;
Wong, YF ;
Cheung, JLK ;
Chan, DPC ;
Hui, M ;
Margaret, IP .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) :243-245
[6]  
Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249
[7]   Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in Southern China [J].
Chan, PKS ;
Lam, CW ;
Cheung, TH ;
Li, WWH ;
Lo, KWK ;
Chan, MYM ;
Cheung, JLK ;
Xu, LY ;
Cheng, AF .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (05) :696-700
[8]  
Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt
[9]  
232::AID-JMV18&gt
[10]  
3.0.CO